Detection of insulin mRNA in the peripheral blood after human islet transplantion predicts deterioration of metabolic control
Autor: | Thierry Berney, Philippe Morel, A. M. James Shapiro, P.Y. Benhamou, M-C Brulhart, Domenico Bosco, Jacques Philippe, Christian Toso, Anne Wojtusciszyn, Mathieu Pierre Jean Armanet, Reto M. Baertschiger, Aline Mamin, Sandrine Demuylder-Mischler, Beate Ritz-Laser |
---|---|
Přispěvatelé: | Centre de pharmacologie et innovation dans le diabète (CPID), Université Montpellier 1 (UM1)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Centre National de la Recherche Scientifique (CNRS) |
Jazyk: | angličtina |
Rok vydání: | 2006 |
Předmět: |
Male
RNA Messenger/genetics medicine.medical_treatment Islets of Langerhans Transplantation 030230 surgery 0302 clinical medicine Leukocytes Immunology and Allergy Insulin Pharmacology (medical) Whole blood ddc:616 0303 health sciences geography.geographical_feature_category MESH: Middle Aged ddc:617 Graft Survival Insulin/genetics [SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism Middle Aged Islet Reverse transcription polymerase chain reaction surgical procedures operative Leukocytes/metabolism Female Islets of Langerhans/pathology/physiology Adult medicine.medical_specialty endocrine system MESH: Graft Survival MESH: Insulin MESH: Leukocytes 03 medical and health sciences Islets of Langerhans Internal medicine Diabetes mellitus medicine Humans RNA Messenger Pancreatic hormone 030304 developmental biology MESH: RNA Messenger Transplantation geography Type 1 diabetes MESH: Humans business.industry MESH: Islets of Langerhans MESH: Adult medicine.disease MESH: Male Endocrinology MESH: Islets of Langerhans Transplantation business MESH: Female |
Zdroj: | American Journal of Transplantation, Vol. 6, No 7 (2006) pp. 1704-11 BASE-Bielefeld Academic Search Engine American Journal of Transplantation American Journal of Transplantation, Wiley, 2006, 6 (7), pp.1704-11. ⟨10.1111/j.1600-6143.2006.01373.x⟩ |
ISSN: | 1600-6135 1600-6143 |
DOI: | 10.1111/j.1600-6143.2006.01373.x⟩ |
Popis: | International audience; Recent updates of the Edmonton trial have shown that insulin independence is progressively lost in approximately 90% of islet transplant recipients over the first 5 years. Early prediction of islet graft injury could prompt the implementation of strategies attempting to salvage the transplanted islets. We hypothesize that islet damage is associated with the release and detection of insulin mRNA in the circulating blood. Whole blood samples were prospectively taken from 19 patients with type 1 diabetes receiving 31 islet transplants, immediately prior to transplantation and at regular time-points thereafter. After RNA extraction, levels of insulin mRNA were determined by quantitative reverse tran-scriptase-polymerase chain reaction. All patients exhibited a primary peak of insulin mRNA immediately after transplantation, without correlation of duration and amplitude with graft size or outcome. Twenty-five subsequent peaks were observed during the follow-up of 17 transplantations. Fourteen secondary peaks (56%) were closely followed by events related to islet graft function. Duration and amplitude of peaks were higher when they heralded occurrence of an adverse event. Peaks of insulin mRNA can be detected and are often associated with alterations of islet graft function. These data suggest that insulin mRNA detection in the peripheral blood is a promising method for the prediction of islet graft damage. |
Databáze: | OpenAIRE |
Externí odkaz: |